Search

Purpose: To compare the severity of postoperative pain and the rate of penetration of riboflavin between eyes treated by corneal crosslinking (CXL) using excimer laser superficial epithelial removal and mechanical full-thickness epithelial removal., Setting: Departments of Ophthalmology, Ullevål University Hospital, Oslo, and University Hospital of Northern Norway, Tromsø, Norway., Methods: Patients with corneal ectasia were treated with superficial corneal epithelial removal using the excimer laser programmed to 35 mum of phototherapeutic keratectomy (Group 1) or mechanical full-thickness epithelial removal with a brush (Group 2). Pain was evaluated postoperatively by the patients' subjective evaluation and need for analgesia. The duration of topical application of riboflavin to achieve stromal saturation was measured., Results: Thirty eyes of 30 patients, 15 in each group, were treated. Postoperative pain was severe in 40.0% of patients in Group 1 and in no patient in Group 2 (P = .009) and moderate in 53.3% and 33.3%, respectively (no significant difference). The mean time to riboflavin saturation was 43.7 minutes +/- 10.8 (SD) in Group 1 and 31.3 +/- 3.0 minutes in Group 2 (P = .001)., Conclusion: Superficial epithelial removal using the excimer laser resulted in more postoperative pain and the need for prolonged application of riboflavin to achieve corneal saturation.

Background: Eye banks have procured, processed and stored donor corneas for decades. In parallel, new techniques have emerged employing allogeneic transplantation of various cells and tissues from the eye banks. This progress is a consequence of increased knowledge of stem cells, cell kinetics and immunological aspects and improved techniques for cell culturing, tissue storage and microsurgery., Material and Methods: Review article on available transplants for treating eye diseases, based on experience with eye banking, clinical ophthalmological practice, own research and literature retrieved from PubMed, Medline and www.google.com., Results and Interpretation: Treatment techniques for eye diseases, which require biological material for grafting, need efficient eye banks for continuous supply of donor material of high quality. New Norwegian legislation, based on implementation of EU Directive 2004/23/EC, demands authorization of all eye banks. The EU Directive sets high and rigorous standards for quality and safety for donation, procurement, testing, processing, storage and distribution of tissues and cells. Well-run eye banks are of great importance for modern treatment of patients suffering from eye diseases and for progress and research in ophthalmology.